Wolverine Trading’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-17,000
| Closed | -$105K | – | 7387 |
|
|
2021
Q3 | $105K | Buy |
+17,000
| New | +$106K | ﹤0.01% | 5749 |
|
|
2021
Q2 | – | Sell |
-11,100
| Closed | -$96K | – | 7081 |
|
|
2021
Q1 | $96K | Buy |
+11,100
| New | +$127K | ﹤0.01% | 5452 |
|
|
2020
Q3 | – | Sell |
-14,400
| Closed | -$183K | – | 5427 |
|
|
2020
Q2 | $183K | Sell |
14,400
-12,000
| -45% | -$124K | ﹤0.01% | 3882 |
|
|
2020
Q1 | $217K | Sell |
26,400
-33,600
| -56% | -$506K | ﹤0.01% | 3602 |
|
|
2019
Q4 | $1.23M | Buy |
60,000
+35,000
| +140% | +$590K | ﹤0.01% | 2219 |
|
|
2019
Q3 | $348K | Buy |
25,000
+11,700
| +88% | +$139K | ﹤0.01% | 3010 |
|
|
2019
Q2 | $164K | Sell |
13,300
-1,200
| -8% | -$13.8K | ﹤0.01% | 3821 |
|
|
2019
Q1 | $181K | Sell |
14,500
-6,700
| -32% | -$89.5K | ﹤0.01% | 3899 |
|
|
2018
Q4 | $252K | Buy |
21,200
+6,800
| +47% | +$107K | ﹤0.01% | 3417 |
|
|
2018
Q3 | $269K | Buy |
+14,400
| New | +$331K | ﹤0.01% | 3878 |
|
|
2018
Q1 | – | Sell |
-10,800
| Closed | -$270K | – | 6113 |
|
|
2017
Q4 | $270K | Sell |
10,800
-6,500
| -38% | -$159K | ﹤0.01% | 3774 |
|
|
2017
Q3 | $418K | Sell |
17,300
-4,000
| -19% | -$94K | ﹤0.01% | 2824 |
|
|
2017
Q2 | $438K | Buy |
21,300
+9,400
| +79% | +$196K | ﹤0.01% | 2577 |
|
|
2017
Q1 | $322K | Sell |
11,900
-1,500
| -11% | -$30.6K | ﹤0.01% | 2938 |
|
|
2016
Q4 | $255K | Buy |
+13,400
| New | +$256K | ﹤0.01% | 3447 |
|
Wolverine Trading's FLXN Position: Q4 2019 in Review
Wolverine Trading sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2019, closing a stake of 18,460 shares — an estimated $311K sold.
Wolverine Trading first reported a position in FLXN in Q1 2017 and held it in 8 quarters. The position peaked at $422K in Q4 2018. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.
- Wolverine Trading reported no remaining Flexion Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
- Wolverine Trading sold 18,460 Flexion Therapeutics, Inc. shares in Q4 2019, an estimated $311K.
- Wolverine Trading first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and held it in 8 quarters.
- Wolverine Trading's Flexion Therapeutics, Inc. position peaked at $422K in Q4 2018.
- 133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.
Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.